BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35834884)

  • 1. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
    Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
    Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of papillary thyroid carcinoma with tall-cell features.
    Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R
    Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma tall cell variant.
    Ghossein R; Livolsi VA
    Thyroid; 2008 Nov; 18(11):1179-81. PubMed ID: 18925842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.
    Ghossein RA; Leboeuf R; Patel KN; Rivera M; Katabi N; Carlson DL; Tallini G; Shaha A; Singh B; Tuttle RM
    Thyroid; 2007 Jul; 17(7):655-61. PubMed ID: 17696836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
    Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
    Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
    Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Ince S; Arslan N
    Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
    Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
    Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
    Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
    Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.
    Morris LG; Shaha AR; Tuttle RM; Sikora AG; Ganly I
    Thyroid; 2010 Feb; 20(2):153-8. PubMed ID: 20151822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinicopathological features and oncologic outcomes of the classic papillary thyroid carcinoma with tall cell features and tall cell variant.
    Kim K; Jung CK; Lim DJ; Bae JS; Kim JS
    Gland Surg; 2022 Jan; 11(1):56-66. PubMed ID: 35242669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.
    Lee SH; Jung CK; Bae JS; Jung SL; Choi YJ; Kang CS
    Diagn Cytopathol; 2014 Jan; 42(1):11-7. PubMed ID: 23754825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.
    Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
    World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
    Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
    Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
    Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
    Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
    J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
    Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of fine-needle aspiration and core needle biopsies in the diagnosis of tall cell variant of papillary thyroid carcinoma.
    Ahn J; Jin M; Kim WG; Kim TY; Kim WB; Shong YK; Baek JH; Song DE; Jeon MJ
    Clin Endocrinol (Oxf); 2023 Jan; 98(1):110-116. PubMed ID: 35394662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?
    Danilovic DLS; Castroneves LA; Suemoto CK; Elias LO; Soares IC; Camargo RY; Correa FA; Hoff AO; Marui S
    Thyroid; 2020 Jul; 30(7):1008-1016. PubMed ID: 32059626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.